Nanomedicine News

RSS

UCSB Researchers Design Novel Silver Nanoparticle for Efficient Drug Delivery

Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique — and important — properties. Spherical in shape and silver in composition, it is encased in a shell coated with a peptide that enables it to target tumor cells. What's more, the shell is etchable so those nanoparticles that don't hit their target can be broken down and eliminated. The research findings appear today in the journal Nature Materials.

9 Jun 2014

Avidity NanoMedicines’ Scientific Co-Founder to be Honored with Coveted Award

Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that its scientific co-founder, Mark E. Davis, Ph.D., will receive the 2014 Prince of Asturias Award for Technical and Scientific Research.

9 Jun 2014

Short Pristine Carbon Nanotubes Can Deliver Drugs to Pancreatic Cancer Cells

Short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within, according to researchers at Rice University and the University of Texas MD Anderson Cancer Center.

6 Jun 2014

NanoViricides CEO to Provide Update on Drug Programs at LD Micro Invitational Conference

NanoViricides, Inc. (the “Company”) reports that its CEO, Dr. Eugene Seymour, MD, MPH, will be presenting at the LD Micro Invitational Conference today at 5pm Pacific Time at the Luxe Sunset Boulevard Hotel in West Los Angeles.

From NanoViricides, Inc 5 Jun 2014

New Sustained-Release Nanomedicine for Glaucoma

Scientists from Nanyang Technological University (NTU) and the Singapore Eye Research Institute (SERI) have jointly developed a new nanomedicine that will allow glaucoma patients to do away with daily eye drops.

5 Jun 2014

New Report on Global Nanobiotechnology Applications, Markets and Companies

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Global Nanobiotechnology Applications, Markets and Companies Report 2014-2023" to their offering.

From Research and Markets 4 Jun 2014

Nanobiotix’s NBTXR3 NanoXray Phase I Clinical Study Results Presented at ASCO

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced the successful completion of the first in human study of its lead NanoXray product, NBTXR3, which will be presented today at the American Society of Clinical Oncology (ASCO) annual meeting.

From Nanobiotix 2 Jun 2014

Plasmonic Nanobubbles Can Detect and Kill Only Cancer Cells

The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice’s “quadrapeutics” technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.

2 Jun 2014

Gold Nanoparticle Sensor-Based Test Can Detect, Distinguish Lung Cancer

Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled breath can not only distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), but can also define the stage of any cancer present.

2 Jun 2014

CCNE Reaccredits CNSE/SUNYIT’s Baccalaureate and Master’s Degree Nursing Programs

The newly merged SUNY College of Nanoscale Science and Engineering (CNSE) / SUNY Institute of Technology (SUNYIT) has announced that its top-tier baccalaureate and master’s degree nursing programs have received reaccreditation for the next ten years from the Commission on Collegiate Nursing Education (CCNE).

From College of Nanoscale Science and Engineering, University at Albany 2 Jun 2014